Evvy raises $40M as it seeks to further women’s health research with vaginal microbiome data
Women's health company Evvy announced Tuesday a $40 million Series B led by Catalio Capital Management.
Useful takeaways from this story.
Women's health company Evvy announced Tuesday a $40 million Series B led by Catalio Capital Management.
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
Women's health company Evvy announced Tuesday a $40 million Series B led by Catalio Capital Management.
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.